Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

Healthcare Cannabis
THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

THC Biomed Intl Ltd > Some news
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Post by Ofwoodon Apr 08, 2024 9:43am
406 Views
Post# 35976483

Some news

Some newsFrom last two months fillings https://thecse.com/listings/thc-biomed-intl-ltd/cse-filings/

On March 13, 2024, THC BioMed announced that it has changed its auditor from Baker Tilly WM LLP, Chartered Professional Accountants (the “Former Auditor”) to Davidson & Company LLP, Chartered Professional Accountants (the “Successor Auditor”) effective March 8, 2024. At the request of THC BioMed, the Former Auditor resigned as auditor for THC BioMed effective March 8, 2024, and the board of directors of THC BioMed appointed the Successor Auditor as the replacement auditor for THC BioMed effective March 8, 2024, until THC BioMed’s next annual general meeting.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities